iVascular, CataloniaBio & HealthTech member, launches the open innovation program innoVasc aimed at start-ups in the biomedical field and health.

Marc Amorós, Head of Innovation at iVascular, says "we want to promote innovation and transform vascular therapies to provide our customers with advanced treatments for the diseases of the cardiovascular system". 

Specifically, proposals, approaches, solutions and ideas for vascular therapies from the following areas of interest:

• Medical devices for the treatment of vascular disorders
• Drug delivery systems for local treatments
• Replacement of open surgery with minimally invasive procedures

The deadline for participation is until August 30, 2019.

iVascular was founded in 2010 in Barcelona and is commercially active in more than 66 countries. By the end of 2018 it acquired 10% of the shares of the American startup NaviGate Cardiac for €8.7 million.

More information